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Abstract
Background: Diverging perceptions between individual patients with somatic diseases and their healthcare professionals
might cause problems in communication and decision-making. To date, no measurement tool is available to compare
the illness perceptions between these two groups. The Revised Illness Perception Questionnaire (IPQ-R) is a validated,
widely used instrument in many patient populations with somatic conditions. The aim of this study was to adapt the
IPQ-R to a healthcare professional’s version (IPQ-R HP) and to perform a preliminary evaluation of its validity and reliability.
Methods: After adaptation of the IPQ-R HP, 17 doctors from 3 general hospitals and 9 head nurses from a university
hospital evaluated the face and content validity of the IPQ-R HP. The results were quantified using the content validity
index (CVI) and a modified kappa index (k*). For the reliability measurements a group of nurses from 4 nursing wards
participated at 2 time points with an interval of 4 weeks. Internal consistency and test-retest reliability were calculated.
Results: Twenty-eight of the 38 items demonstrated excellent content validity and four items showed good
content validity. Four items had a sufficient k* and two items had a low CVI. The average CVI of the 7 dimensions
ranged from 0.66 to 0.89. The Cronbach’s alpha scores for the seven dimensions, intraclass coefficients and effect
size estimates were acceptable.
Conclusions: This preliminary evaluation of the IPQ-R HP shows an acceptable to good validity and reliability. Further
exploration of the psychometric properties of this questionnaire in a large cohort of healthcare professionals is warranted.
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Background
Illness perceptions are the cognitive beliefs that patients
have about their condition. They refer to the cognitive
depiction of an illness, reflecting how the illness is ‘pic-
tured and stored’ in the mind [1, 2]. Illness perceptions
directly influence the individual’s emotional response to
the illness and guide coping behaviour such as adher-
ence to treatment and health care use in a positive or
negative way [1, 3, 4]. Over time, researchers have used
various methodologies to measure the patients’ illness
perceptions, ranging from questionnaires in early studies
to in-depth semi-structured interviews [5].
Unfortunately, these questionnaires were not based on
a generally accepted theory nor were they evaluated in
different patient groups [6, 7].
Currently, the majority of studies focusing on patients’
illness perceptions are based upon Leventhal’s Self-
Regulatory Model. In 1980, Leventhal and colleagues [8]
developed this theoretical framework to explain why and
how illness representations can differ. They identified dif-
ferent components including the labels, timeline, cause(s),
consequences and control. This work resulted in the de-
velopment of the Illness Perception Questionnaire (IPQ)
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that assesses these five components of illness representa-
tion. A revised version (IPQ-R) was developed in 2002 by
Moss-Morris and colleagues [9]. The IPQ-R is widely used
in various patient populations such as systemic sclerosis
[10] rheumatoid arthritis [11, 12], psoriasis [13] and can
be modified for use in a particular disease of interest. It
has good psychometric properties with a good internal re-
liability, discrimination and predictive validity and has
already been translated in different languages [9].
In daily clinical practice, the patient and the healthcare
professional (HP) often have different views on the ill-
ness and its impact on a particular patient. Awareness of
these divergent illness perceptions is crucial, as they can
result in misunderstandings and disrupted communica-
tion when unrecognized [14–16]. Previous research
evaluating the patient-professional encounter described
clear differences between the perceptions of the patients
with chronic obstructive pulmonary disease and asthma
on the one hand and the physicians and nurse specialists
on the other hand concerning timeline, control, conse-
quences and outcomes [17]. Interestingly, a Japanese
study [18] demonstrated that a gap between the patient’s
and the doctor’s perceptions was the most significant
predictor of doctor-shopping behaviour.
Detection of misperceptions is possible by matching a
scale that assesses patients’ perceptions and perceptions
of healthcare professionals (HPs). There is no appropri-
ate and validated instrument available to measure illness
perceptions of HPs caring for patients with physical
diseases. At this moment questionnaires are available to
measure lay perceptions of healthy people [19], illness
perceptions of carers of schizophrenia patients [20] and
a modified version of the illness perception question-
naire for mental health practitioners [21]. In the latter
study the utility of a modified version of the IPQ was
investigated to detect changes in mental health practi-
tioners’ illness perceptions about schizophrenia after under-
taking psychosocial intervention training. The modified
IPQ was completed before and after the training. After-
wards the psychometric properties of the modified IPQ
were tested using confirmatory factor analysis showing that
a six factor model was most appropriate, but also that there
was a poor fit of the items in each factor. This implied that
the instrument was not valid and reliable enough to detect
changes in illness perceptions.
The purpose of this study was to adapt the IPQ-R to a
healthcare professional’s version and to perform a pre-
liminary evaluation of its validity and reliability.
Methods
The first step in the methodology was an adaptation
and rewording of the IPQ-R to a healthcare profes-
sionals version. Secondly, face validity and content val-
idity of this adapted version was evaluated in a group of
physicians and head nurses. At last, the reliability mea-
surements, i.e. the internal consistency and test-retest
reliability, were assessed in a group of nurses.
Adaptation/rewording of the IPQ-R for healthcare
professionals
Four authors (SA, PM, JV and RW) discussed and agreed
upon the adaptation of the 9-dimension Dutch version
of the IPQ-R [22] to a healthcare professionals version
(IPQ-R HP). This process comprised several rounds. An
item-by-item approach was followed by a dimensional
and overall evaluation. The primary goal of the process
was to focus on the perception of the HP regarding the
disease of a particular patient (dimensions 1, 2, 3, 4 and
6). The secondary focus of the IPQ-R HP was the view
of the HP on the perceptions of that particular patient,
regarding his/her illness and about its emotional impact
on the patient (dimensions 5 and 7). The reformulation
of the latter 2 dimensions was done in this way because
these dimensions have an emphasis on the emotionality
and understanding of the patient and not on the disease
of the patient. We did not include the dimensions ‘ill-
ness identity’ (= perceptions of symptoms associated
with the illness) and ‘causal attributions’ in the IPQ-R
HP. From a HP’s perspective, these 2 dimensions are
also part of illness perceptions but more related to med-
ical knowledge or a medical judgment of the illness in
comparison with patients’ illness perceptions because of
their biomedical education. The other 7 dimensions of
the original IPQ-R were reworded to a HP’s version.
Finally, this IPQ-R HP consisted of 7 dimensions: 1)
consequences (the HPs’ perception of the consequences
of the illness for a particular patient); 2) timeline acute/
chronic (the HPs’ perception about the illness passing
quickly or not in a particular patient); 3) personal
control (the HPs’ perception of the patient’s ability to
control the illness); 4) treatment control (the HPs’ per-
ception about the effectiveness of any treatment or
approach to control the illness in a particular patient);
5) illness coherence (the HPs’ perception of the extent
to which a particular patient understands their illness);
6) timeline cyclical (the HPs’ perception of the cyclical
nature of the illness across time); and 7) emotional
representations (the HPs’ perception of the patients’
emotional experience of their illness). In general, be-
sides the rewording and reformulation, the difference
between the IPQ-R and IPQ-R HP were the terms ‘I’
and ‘this patient’.
Sampling strategy - procedure
To measure the face and content validity, a purposive
sampling strategy was conducted. We had a list with the
names of 20 physicians from 3 general hospitals and 11
head nurses from a large university hospital in Belgium
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and invited them to participate. Two sampling criteria
were used to recruit the healthcare professionals: they
had to be specialised in internal medicine and have ac-
tive patient contact at an outpatient clinic or inpatient
service. They were visited in their respective hospitals
and introduced in the study (by AVdZ and MVR). Oral
and written information about the study was given to-
gether with the scoring instructions and the IPQ-R HP.
After one week, researchers AVdZ and MVR contacted
the physicians and head nurses personally and reminded
them to complete the questionnaire if needed.
For the reliability measurement, head nurses of 11 nurs-
ing wards from the university hospital were approached
and asked if their nurses could participate. At these 11
nursing wards a total of 242 nurses are working. We opted
for nurses to score the reliability measurements because for
the face and content validity measurements already more
physicians than nurses were present. Nurses received first
oral information during a team meeting, after which they
received written information regarding the study. They
were asked to complete the IPQ-R HP on the basis of 4
patient vignettes. After an interval of 4 weeks, they were
asked to complete the IPQ-R HP on the basis of 1 patient
vignette that was included in the first round. The reason
for reducing the number of vignettes from 4 to 1 was the
indication of survey fatigue among respondents which
could have an impact on the response rate. These patient
vignettes were developed by SA and RW and comprised
information regarding 2 patients with Systemic Lupus Ery-
thematosus and 2 patients with Systemic Sclerosis based on
real patients seen in the clinic. The information in the vi-
gnettes pertained to the patients’ clinical condition (i.e. a
description of antibody profile, characteristics and compli-
cation of the disease), the medical treatment and eventual
psychosocial complications and coping styles having a pos-
sible or probable impact on daily life (see Additional file 1).
Validity
Face Validity
Face validity is the extent to which a test is representa-
tive for covering the concept it purports to measure at
first sight [23]. The IPQ-R HP was accompanied by four
questions about each dimension and also a general ques-
tion at the end. These four questions were: “Are these
questions a correct representation of the dimension?”;
“Are the questions clear?”, “Are there questions lacking?”
and “Are there redundant questions?” At last, there was
an open question for further remarks. The reason why
we asked, if the items per dimension are representative
for a particular dimension, is because the concept of ill-
ness perceptions consists of several dimensions. So, we
used the theory behind the concept of illness percep-
tions [8] as a backbone to rely on. In this phase, the
emphasis was on the representativeness of the items
covering the concept on first sight and not on removing
or adding new items because of their content [24].
Content validity
The IPQ-R HP was also tested for content validity. Con-
tent validity is the extent to which a measure represents
all facets of a given construct [25]. In other words, the
items on the test represent the entire range of possible
items the test should cover [26, 27].
Physicians and head nurses, this was the same group
as for the appraisal of the face validity, were instructed
to rate the 38 items of the IPQ-R HP on a 4-point Likert
scale as: “1 = not relevant”, “2 = somewhat relevant”, “3 =
quite relevant”, “4 = highly relevant”. An appropriate
sample size for calculating content validity ranges be-
tween 5 and 10 [26].
Based on these data, the item Content Validity Index
(I-CVI) was calculated. The I-CVI is the proportion of
items that received a rating of 3 or 4 by the experts. For
the total instrument and each scale, a scale content
validity index (S-CVI) was calculated. This is the average
of all the I-CVI’s of the individual items (S-CVIave). An
I-CVI of 0.78 and an S-CVIave of 0.90 is considered to
be excellent [27].
To counter the limitations of the CVI, each I-CVI was
adjusted for chance agreement by calculating the modi-
fied kappa statistic (k*) [28]. To compute the modified
kappa, the probability of chance agreement was com-
puted first: Pc = [N!/A! (N −A)!] × 0.5
N where N is the
number of experts and A is the number agreeing on
good relevance (rating 3 and 4). Next, the k* was calcu-
lated with the formula k* = [I-CVI− Pc ]/[1− Pc] [26].
According to the standards of Fleiss [29] and Cicchetti
and Sparrow [30] the value of each k* was evaluated as
poor (k <0.40), fair (k of 0.40 to 0.59), good (k of 0.60 to
0.74), or excellent (k of > 0.74).
Reliability
To measure the internal consistency, Cronbach’s alpha
values per vignette were calculated and also a total
Cronbach’s alpha value was computed. Sample size esti-
mations to accurately determine the internal consistency
showed that a minimum of 17 subjects was necessary.
To evaluate the test-retest reliability, nurses were asked at
time point 1 (T1) to complete the 4 vignettes and at time
point 2 (T2) they were asked to complete vignette number
4 because this vignette had the best alpha values and the
content was a good mix of psychosocial and clinical infor-
mation. Intraclass correlation (ICC) was computed to
describe how strongly illness perception dimensions in the
same group resemble each other. It is a measure of the reli-
ability of measurements. ICC can be interpreted as
follows: 0–0.2 = poor agreement; 0.3-0.4 = fair agree-
ment; 0.5-0.6 = moderate agreement; 0.7-0.8 = strong
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agreement; and >0.8 = almost perfect agreement. These
values are arbitrary cutoffs, but similar to those used
by Landis and Koch [31] for agreement of categor-
ical items.
We also looked for differences in illness perception
scores between T1 and T2 which are expressed in effect
sizes. For the continuous variables, an effect size for the
Wilcoxon signed rank test was calculated by r ¼ Zﬃﬃﬃ
N
p
where Z is the normal approximation of the Wilcoxon
test statistic and N is the total number of participants on
which Z is based. To appraise the magnitude of the ef-
fect sizes we used the cutoff values for Cohen’s r: small
effect size = between 0.10 and 0.30; medium effect size =
between 0.30 and 0.50 and large effect size = 0.50 or
higher [32].
Statistical analysis
Descriptive statistics were used to calculate the I-CVI
values, the S-CVIave values, the Pc and k*. These data
were analysed using Microsoft Excel (version 2011). The
calculation of the Cronbach’s alpha, ICC and Wilcoxon
signed rank test was carried out with SPSS version 22.0.
Results
Experts scoring validity
Seventeen doctors and 9 head nurses participated (re-
sponse rate = 84 %). The sample of the physicians con-
sisted of 9 men and 8 women and was composed of 4
gastroenterologists; 3 endocrinologists; 2 rheumatologists;
2 cardiologists; 2 pulmonologists; 1 nephrologist; 1 neur-
ologist; 1 dermatologist and 1 oncologist. No further
demographic data were available. The 3 doctors who did
not participate were all men and gave a lack of time as a
reason for not participating. The 9 head nurses, 6 women
and 3 men, worked at following disciplines: cardiology;
gastroenterology; rheumatology; nephrology; gynecology;
ophthalmology; otorhinolaryngology and 2 pulmonology
wards. One head nurse declined participation because of
insecurity concerning scoring the questions correctly. The
other gave no reason.
Face validity
In Table 1, the face validity scores of the IPQ-R HP are
tabulated. One of the 9 head nurses did not score the
face validity questions. For almost all healthcare profes-
sionals, the questions were a correct representation of
the dimensions and the questions were clear. Physicians
wanted to add more questions such as items concerning
self-appearance, autonomy and quality of life in the
‘Consequences’ dimension. In the ‘Timeline’ dimension
they wanted to add questions regarding curability of the
patient and worsening of the disease. The most redun-
dant or overlapping questions for the physicians and
head nurses were found in the dimensions Timeline
acute/chronic; Personal control; Illness coherence and
Emotional representations. More specifically, for the di-
mension ‘timeline acute/chronic’, the experts found an
overlap in items 7, 8, 10 & 11. For the dimension ‘per-
sonal control’, following items were comparable for the
experts: 14, 15, 17, 18. For the dimension ‘illness coher-
ence’, the experts scored items 25, 26, 27 as comparable
items. For the dimension ‘emotional representations’,
items 37 & 38 were comparable.
Content validity
A total of 16 physicians and 9 head nurses completed
the 4-point Likert scale (see Table 2). Three doctors did
not complete one question or one dimension. They gave
no reason why they left these items blank. This means
that 12 items were rated by 15 doctors and 26 items
were assessed by 16 doctors.
Twenty-eight of the 38 items had an excellent con-
tent validity (I-CVI ≥ 0.78 and k* > 0.74), 4 of the 38
items had a good content validity (I-CVI <0.78 and
0.60 ≤ k* ≤ 0.74) and 4 of the 38 items had a fair con-
tent validity (I-CVI <0.78 and 0.40 ≤ k* ≤ 0.59) (see
Table 1). Two items (item 4 and item 10) had a very
low modified kappa (k* < 0.40) and were considered
content invalid.
The average scale content validity (S-CVIAve) for each
of the 7 dimensions was as follows: Consequences was
0.75; Timeline acute/chronic was 0.75; Personal control
was 0.81; Treatment control was 0.89; Illness coherence
was 0.74; Timeline cyclical was 0.66; and Emotional rep-
resentations was 0.77. The S-CVIAve for the entire ques-
tionnaire was 0.79.
After omitting items with a fair and very low k* value
the S-CVIAve for Consequences was 0.88 (without item 3
and 4), for Timeline acute/chronic was 0.83 (without
item 10), Illness coherence was 0.88 (without item 25
and 27) and Emotional representations was 0.80 (with-
out item 34). The S-CVIAve for the entire questionnaire
after removing items 3, 4, 10, 25, 27 and 34 was 0.82.
For the group of the nurses, very low modified
kappa values (k* < 0.40) were present for item 3 (k* =
0.26), 10 (k* = 0.09) and 27 (k* = 0.26). Item 4 had a k*
value of 0.42.
Experts scoring reliability
Four head nurses of following wards agreed with the
participation of their nurses: pulmonology, rheumatol-
ogy, nephrology and internal medicine. A total of 20
nurses gave consent for participation, comprising 15
women and 5 men, with a mean age of 39 years (SD =
12) and mean years of working experience of 17 years
(SD = 12). Information about the non-responders is
not available.
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Internal consistency
Depending on the sample size estimations, a sample of
20 nurses was large enough to adequately compute the
Cronbach’s alpha. Total Cronbach’s alpha values on all
vignettes rated by 20 nurses are: Consequences = 0.78;
Timeline acute-chronic = 0.77; Personal control = 0.80;
Treatment control = 0.50; Illness coherence = 0.75; Time-
line cyclical = 0.80; Emotional representations = 0.86 (see
Table 3).
Test-retest reliability
Thirteen nurses completed the IPQ-R HP on the basis
of vignette 4 at T2. Table 4 displays the ICC values and
Wilcoxon z-score with effect size calculation for all di-
mensions. The ICC values were strong for all dimen-
sions, except for Personal control (ICC = 0.444) and
Timeline cyclical (ICC = 0.417). For the latter two di-
mensions the ICC values can be considered as fair which
means that there is a fair agreement of Personal control
and Timeline cyclical at the two time points. The effect
size estimates between the 2 moments was small, which
means that differences in the scores of the nurses be-
tween the two time points were small.
Discussion
The purpose of this study was to adapt and to perform a
preliminary evaluation of the validity and reliability of
the IPQ-R HP. At first sight, this IPQ-R HP has a good
and acceptable face and content validity, and reliability.
Experts judged the majority of the items as relevant.
Item 4 and 10 were the only items with a poor or very
low kappa value, indicating that these items are not valid
to measure the construct, i.e. illness perceptions. None-
theless, we decided to keep all items in the IPQ-R HP
and did not omit item 4 and 10. The reason why we did
not delete item 4 and 10 was that these low scores are
probably due to the fact that a mix of professions, nurses
and physicians, scored these items which means that
they maybe gave a different meaning or interpretation to
this. Only a confirmatory factor analysis can give infor-
mation about items that certainly should be omitted.
The internal consistency of the 7 dimensions was ac-
ceptable and the instrument had overall good scores for
the reliability measurements except for the treatment
control dimension. The treatment control dimension
with an alpha value of 0.50 (calculated for all vignettes)
was the lowest in comparison with the other dimensions.
Literature [33] states that possible reasons for a low
value of alpha could be a low number of questions, poor
interrelatedness between items or heterogeneous con-
structs. Therefore, we think that in our study a combin-
ation of a low number of items -namely, 5 items- and a
low interrelatedness of these items are possible reasons
why the treatment control dimension has the lowest
alpha value in comparison with the other dimensions.
On the other hand, experts in our study had the opinion
that the items of the treatment control dimension were
representative for this dimension at first sight and they
also scored the content validity of this dimension as
excellent. Probably a confirmatory factor analysis in a
large sample of HPs can give us more insight. By com-
parison of the alpha values of the study of Fleming et al.
[21] with the total alpha values of our study, we found
that our alpha scores were higher. A possible reason is
that in our study at least 4 items per dimension are
present. The study of Fleming et al. [21] had 2 items per
dimension. Fleming et al. [21] not only calculated Cron-
bach’s alpha values, but went a step further and used fac-
tor analysis to determine the underlying structure of the
IPQ that they modified. The authors stated that a six
factor model was the most appropriate model in com-
parison with a five factor model or one-dimensional
model. However, no extra information was given about
the p-values or correlations between the items and con-
struct (factor) in the model. Their shortcoming was also
the limited number of items (2) per factor leading to a
non-representative result. A strength was the sample
size of 245 mental health practitioners which was suffi-
cient for this kind of analysis.
Table 1 Overview appraisal face-validity of the IPQ-R HP
Dimension Are the questions a
correct representation
of the dimension?
Are the questions clear? Are there questions lacking? Are there questions
redundant?
Doctors n = 17 Nurses n = 8 Doctors n = 17 Nurses n = 8 Doctors n = 17 Nurses n = 8 Doctors n = 17 Nurses n = 8
Consequences 17/17 8/8 17/17 6/8 4/17 1/8 6/17 1/8
Timeline acute/chronic 16/17 8/8 15/17 8/8 4/17 0/8 7/17 4/8
Personal Control 14/17 8/8 14/17 8/8 2/17 0/8 8/17 3/8
Treatment Control 15/17 8/8 14/17 7/8 1/17 0/8 2/17 2/8
Illness Coherence 15/17 8/8 12/17 7/8 1/17 0/8 7/17 4/8
Timeline Cyclical 15/17 8/8 15/17 8/8 3/17 0/8 4/17 2/8
Emotional Representations 15/17 8/8 15/17 8/8 2/17 0/8 12/17 4/8
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Table 2 Evaluation of the content validity of the IPQ-R HP
Item (dimension) Experts (n) Experts with
rating 3 of 4
I-CVIa Pc
b k*c Evaluationd
1 The illness of my patient is serious (1) 25 23 0.92 0.0000 0.92 Excellent
2 The illness of my patient has major consequences on his/her life (1) 25 25 1.00 0.0000 1.00 Excellent
3 The illness of my patient does not have much effect on his/her life (1) 25 13 0.52 0.1550 0.43 Fair
4 The illness of my patient strongly affects the way others see him/her (1) 25 12 0.48 0.1550 0.38 Poor
5 The illness of my patient has serious financial consequences for
him/her (1)
25 18 0.72 0.0143 0.72 Good
6 The illness of my patient causes difficulties for those who are close to
him/her (1)
24 21 0.88 0.0001 0.87 Excellent
7 The illness of my patient will last a short time (2) 25 17 0.68 0.0322 0.67 Good
8 The illness of my patient is likely to be permanent rather than
temporary (2)
25 24 0.96 0.0000 0.96 Excellent
9 The illness of my patient will last for a long time (2) 25 21 0.84 0.0004 0.84 Excellent
10 The illness of my patient will pass quickly (2) 25 8 0.32 0.0322 0.30 Poor
11 I expect that my patient will have his/her illness for the rest of
his/her life (2)
24 19 0.79 0.0025 0.79 Excellent
12 The illness of my patient will improve in time (2) 25 22 0.88 0.0001 0.88 Excellent
13 My patient can do a lot to control his/her symptoms (3) 25 22 0.88 0.0001 0.88 Excellent
14 What my patient does can determine whether his/her illness gets
better or worse (3)
25 21 0.84 0.0004 0.84 Excellent
15 The course of my patients’ illness depends on him/her (3) 25 21 0.84 0.0004 0.84 Excellent
16 Nothing my patient does will affect his/her illness (3) 25 19 0.76 0.0053 0.76 Excellent
17 My patient has the power to influence his/her illness (3) 25 18 0.72 0.0143 0.72 Good
18 The actions of my patient will have no effect on the outcome of
his/her illness (3)
25 21 0.84 0.0004 0.84 Excellent
19 There is very little that can be done to improve the illness of my
patient (4)
25 22 0.88 0.0001 0.88 Excellent
20 The treatment of my patient, will be effective in curing his/her
illness (4)
25 23 0.92 0.0000 0.92 Excellent
21 The negative effects of the illness of my patient can be prevented
(avoided) by his/her treatment (4)
25 23 0.92 0.0000 0.92 Excellent
22 The treatment of my patient can control his/her illness (4) 25 25 1.00 0.0000 1.00 Excellent
23 There is nothing which can help the condition of my patient (4) 25 18 0.72 0.0143 0.72 Good
24 The illness of my patient is a mystery to him/her (5) 25 23 0.92 0.0000 0.92 Excellent
25 The symptoms of the condition of my patient are puzzling to
him/her (5)
25 14 0.56 0.1328 0.49 Fair
26 My patient does not understand his/her illness (5) 25 20 0.80 0.0016 0.80 Excellent
27 The illness of my patient doesn’t make any sense to him/her (5) 25 13 0.52 0.1550 0.43 Fair
28 My patient has a clear picture or understanding of his/her condition (5) 25 23 0.92 0.0000 0.92 Excellent
29 The symptoms of the illness of my patient change a great deal from
day to day (6)
24 19 0.79 0.0025 0.79 Excellent
30 The symptoms of my patient come and go in cycles (6) 24 18 0.75 0.0080 0.75 Excellent
31 The illness of my patient is very unpredictable (6) 24 22 0.92 0.0000 0.92 Excellent
32 My patient goes through cycles in which his/her illness gets better
and worse (6)
24 20 0.83 0.0006 0.83 Excellent
33 My patient gets depressed when he/she thinks about his/her illness (7) 24 20 0.83 0.0006 0.83 Excellent
34 When my patient thinks about his/her illness he/she gets upset (7) 24 15 0.63 0.0779 0.59 Fair
35 The illness of my patient makes him angry (7) 24 19 0.79 0.0025 0.79 Excellent
36 The illness of my patient does worry him/her (7) 24 19 0.79 0.0025 0.79 Excellent
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The strengths of our study are that we conducted this
research in a group of physicians, head nurses and
nurses employed in different medical disciplines and
four hospitals. The sample size to measure the content
validity was also much larger than previously used in
similar studies [26]. The high response rate was probably
due to the personal contact that we had before conduct-
ing the study. Another strength is that almost all physi-
cians and head nurses considered the questions to be
clear and providing a correct representation of the di-
mension at first sight. We were able to keep the original
construction of the questions, which allows for matching
with patients’ questionnaires at individual item level.
The method of Lynn [26] is considered as an extensive
method to evaluate the content validity and has shown
valuable results. The results of both measurements, I-CVI
and k* were in line with each other, with items not meet-
ing the I-CVI criterion of 0.78 not showing excellent k*
values and vice versa, indicating that both methods re-
sulted in the same conclusion and were strengthening
current evidence. For the reliability analyses we calculated
the alpha value for each vignette separately. This gave us
an idea about the amount of influence of the quality of the
vignette on the reliability estimate and revealed that vi-
gnette 4 had the best alpha values.
Shortcomings of this study concerning the validity mea-
surements, is that the use of cognitive interviewing tech-
niques asking physicians and head nurses about their
reflections concerning the individual items would, have
given more background information about questions that
were not clear or were skipped. Another shortcoming was
that the sample size was not large enough to compute a
confirmatory factor analysis because we needed then a
sample between 380–570 healthcare professionals (i.e.
10–15 respondents per item) [34]. A confirmatory factor
analysis would give information regarding the unidimen-
sionality of the subscales and also provides information
about the relationship between each item and the sub-
scale. For the reliability measurements, it was difficult to
motivate the nurses to complete the 4 vignettes and it was
even much more difficult to motivate them to complete
one vignette for a second time. Therefore, we used vi-
gnette 4 for the retest, which was a good mix of clinical
and psychosocial information and had also the highest
alpha value. This could have led to an overestimation of
the intraclass coefficient because we used the vignette
with the highest interrelatedness of items. Reasons for
the low response rate were no time, too many question-
naires and too difficult vignettes. For planning further
research, the number of the vignettes have to be taken
into consideration.
Another limitation was that the reliability estimates
are based just on a sample of nurses. It is unclear
whether these results are generalizable to physicians be-
cause nurses and physicians differ in a variety of aspects
like education, patient contact, responsibility for diag-
nostics and treatment. As a last point to consider we
want to mention that in the adaptation process of the
IPQ-R to the IPQ-R HP we omitted the identity and
causality dimensions of illness representations. Our rea-
soning was that these 2 dimensions are –in comparison
with patients’ perceptions- more related with biomedical
knowledge. A remark on this is on the one hand, that
treatment decisions are often based on physicians’ repre-
sentations of the identity and causal attributions dimen-
sions and on the other hand it is possible that conflicts
Table 2 Evaluation of the content validity of the IPQ-R HP (Continued)
37 Having this illness makes my patient feel anxious (7) 24 19 0.79 0.0025 0.79 Excellent
38 The illness of my patient makes him/her afraid (7) 24 19 0.79 0.0025 0.79 Excellent
aI-CVI (item content validity index) = number giving a rating of 3 or 4 / number experts
bpc (probability of chance occurrence) = [N!/ A!(N-A)!] x 0,5
N where N = number of experts and A = number agreeing on good relevance
ck* = kappa designating agreement on relevance: k* = (I-CVI – pc) / (1 – pc)
dEvaluation criteria for k*: poor = k* < 0.40; fair = k* of 0.40-0.59; good = k* of 0.60-0.74; excellent = k* > 0.74
Table 3 Cronbach’s alpha values for the four patient vignettes
Dimensions IPQ-R HP Alpha value
Vignette 1
Alpha value
Vignette 2
Alpha value
Vignette 3
Alpha value
Vignette 4
Alpha value
All vignettes
Consequences 0.77 0.81 0.73 0.83 0.78
Timeline acute-chronic 0.89 0.67 0.78 0.75 0.77
Personal control 0.80 0.88 0.77 0.76 0.80
Treatment control 0.48 0.66 0.30 0.54 0.50
Illness coherence 0.77 0.63 0.75 0.86 0.75
Timeline cyclical 0.80 0.72 0.84 0.84 0.80
Emotional representations 0.86 0.85 0.93 0.81 0.86
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between patients and physicians arise when they differ
in their opinions about which symptoms relate to a spe-
cific illness or which factors caused a particular disease.
After a comprehensive validation process, we can ex-
plore the potential applications of this questionnaire in
patient care. This tool is useful for investigating the
causes of misunderstandings and conflicts that have
arisen between medical staff and patients. When differ-
ences in perceptions between patients and HPs are de-
tected than these differences can be discussed using this
tool by comparing the patient’s and HP’s version with
each other. In this way, HPs can reflect upon their own
beliefs and how much it differs from patients’ beliefs.
When HPs are aware of these differences they can work
in a patient-centered manner during patient education
sessions which means that some items or some dimen-
sions can be a stepping stone to tailor information for a
particular patient. With the IPQ-R HP areas of disagree-
ment between patients’ and HPs’ perceptions can be pin-
pointed in a more detailed way which is an advantage
because in this way the communication and shared un-
derstanding between HPs and patients can be enhanced.
This is important because doctor–patient communica-
tion is a powerful indicator to achieve quality in care de-
termining patients’ self-management behaviour and
ultimately health outcomes [35, 36].
Practically, the patient can complete their version in
the waiting room- this means before the doctor has seen
him/her- and the doctor or other HP can complete the
IPQ-R HP after the patient’s visit. These questionnaires
can be completed in every setting, i.e. an inpatient or
outpatient setting. It is important that this happens
when the HP has formed an idea about the patient’s
physical and mental condition. The next stage is the
comparison of these 2 instruments which can be done
easily by the HP. We do not think it is useful to
complete this questionnaire each moment the patient
encounters an HP. The completion of these instruments
can have an added value especially at diagnosis and
when there is a flare or acute exacerbation of the pa-
tient’s condition because illness perceptions are relatively
stable but may show some fluctuations at those time
points [37].
Conclusion
The IPQ-R HP appears adequate and useful to assess the
perception of healthcare professionals concerning the
illness of an individual patient and produces -in this pre-
liminary phase- reliable and valid output. A more exten-
sive validation process is needed in a large cohort of
healthcare professionals to explore the psychometric
properties of this questionnaire prior to a widespread
use in clinical practice. Moreover, a large cohort of
healthcare professionals is needed to investigate the fac-
tor structure of the IPQ-R HP with the aim to determine
which of the items best represent each of the illness per-
ception dimensions. In this way it is possible to have
more insight in the construct validity of the IPQ-R HP.
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